维普中文期刊产品整合服务
8篇 您的检索式:作者名="David Mutimer"
    题名 作者 年代 出处 被引量
1Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus显示文摘Robert Perrillo Hie-won Hann David Mutimer Bernard Willems Nancy Leung William M. Lee Alison Moorat Stephen Gardner Mary Woessner Eric Bourne Carol L. Brosgart Eugene Schiff 2004Gastroenterology2004,,1:2
2Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants显示文摘BACKGROUND: The recurrence of chronic hepatitis B after liver transplantation results in increased risk for graft failure and death of patients. Lamivudine has been shown to be effective in the treatment of chronic hepatitis B, but resistance to this agent is common after prolonged administration. METHODS: One patient with chronic hepatitis B virus (HBV) infection developed resistance to lamivudine after 15 months of treatment. The resistance was confirmed by mutation in the HBV DNA polymerase gene. The patient was treated subsequently with adefovir dipivoxil for 7 months. RESULT: HBV DNA and HBsAg were tested negative, but HBeAb and HBsAb were positive. CONCLUSION: This study provides an evidence that adefovir dipivoxil can be effective in the treatment of lamivudine-resistant HBV mutants.Vincent Lai David Mutimer Darius Mirza 2006Hepatobiliary & Pancreatic Diseases International2006,5,1:1
3Outcome of liver transplantation for patients with pulmonary hypertension显示文摘Peter Starkel Alonso Vera Bridget Gunson David Mutimer 2002Liver Transplantation2002,,4:1
4Impact of Donor Age and Year of Transplantation on Graft and Patient Survival Following Liver Transplantation for Hepatitis C Virus显示文摘David J. Mutimer Bridget Gunson John Chen J Berenguer Peter Neuhaus D Castaing J C. Garcia-Valdecasas M Salizzoni Gonzalez E. Moreno Darius Mirza 2006Transplantation2006,,1:1
5LAMIVUDINE WITHOUT HBIg FOR PREVENTION OF GRAFT REINFECTION BY HEPATITIS B: LONG-TERM FOLLOW-UP显示文摘David Mutimer Geoffrey Dusheiko Catherine Barrett Leonie Grellier Monz Ahmed Gaya Anschuetz Andrew Burroughs Stefan Hubscher Amar Paul Dhillon Keith Rolles Elwyn Elias 2000Transplantation2000,,5:1
6Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus显示文摘Robert Perrillo Hie-won Hann David Mutimer Bernard Willems Nancy Leung William M. Lee Alison Moorat Stephen Gardner Mary Woessner Eric Bourne Carol L. Brosgart Eugene Schiff 2004Gastroenterology2004,,1:1
7British HIV A ssociation guidelines for the management of hepatitis viruses in adults infected with HIV 2013显示文摘Ed Wilkins Mark Nelson Kosh Agarwal Dola Awoyemi Eleanor Barnes Sanjay Bhagani Gary Brook Ashley Brown Sheena Castelino Graham Cooke Martin Fisher Anna Maria Geretti Robert James Ranjababu Kulasegaram Clifford Leen David Mutimer Chloe Orkin Emma Page Adri 2013HIV Med2013,,:1
8阿德福韦-拉米夫定联合治疗与乙肝病毒动力学显示文摘核苷和核苷酸类似物是有效的HBV复制抑制剂。拉米夫定(LAM)和阿德福韦(ADV)被批准用于慢性HBV感染患者的治疗,单一药物的疗效大大降低了血清HBV滴度。然而,长期治疗与选择和出现HBV耐药毒株具有相关性。采用HIV治疗的模式,目前正在进行核苷类药物联合治疗HBV可能有益的研究。联合用药将包括抗HBV耐受的药物。David Mutimer 赵春燕(编译) 杨露绮(审校) 2005传染病网络动态2005,,9:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费